Rare Disease MSL
No salary listed
Junior
Master's, PharmD, PhD, MD
Tokyo, Japan
Remote
Biology & Biotech
About the job
Requirements
- Education history in a life-science or relevant area.
- A minimum of 2 years in the pharmaceutical industry or proven industry collaboration in academia.
- Knowledge of thyroid eye disease, ophthalmology, and endocrinology.
- Good communication and negotiation skills with scientific experts and internal stakeholders.
- Native-level Japanese and business-level English.
- Strong communication and presentation skills.
- Ability to work in a cross-functional team across Commercial, Clinical Development, Regulatory, Safety, and other functions.
Responsibilities
- Maximize Amgen's value propositions through medical and scientific projects, services, and expertise with key scientific customers.
- Implement scientific programs in local territories in collaboration with external and internal customers.
- Contribute to medical projects, including evidence-generation activities, large medical events, and publications, to support the business.
- Serve as a key member of the brand team and develop product strategy with the local commercial team.
- Identify, develop, and maintain collaborative relationships with current and future scientific experts and cooperative study groups.
- Discuss scientific value messages, clinical outcomes, and patient benefits with scientific experts and opinion leaders.
- Work with Medical and relevant internal colleagues to create engagement plans for external experts.
- Provide insights from field activity and contribute to local medical and brand strategy activities in accordance with internal and external regulations.
- Identify new research opportunities and support Investigator Sponsored Studies and Amgen Sponsored Trials as necessary.
- Support international and regional congresses through society engagement.
- Implement and disseminate medical and scientific educational programs, providing logistics and medical leadership.
- Support local clinical-trial operations in collaboration with cross-functional development teams.
- Communicate with medical and other relevant organizations of alliance partners to maximize collaboration value.
- Participate in or conduct Local Advisory Board Meetings, Investigator Meetings, and Expert Panels.
- Provide therapeutic-area and product training for internal stakeholders.
- Continuously expand medical, scientific, and market knowledge.
- Act as a role model in line with Amgen Values.
Desired Qualifications
- An advanced degree (Master, PhD, MD, or PharmD).
- Experience in ophthalmology, endocrinology, or immunology.
- Experience in Medical Affairs, Clinical Development, or a relevant field.
- Experience with medical or scientific study management or conduct.
- Knowledge of pharmaceutical product development, product lifecycle, and commercialization processes, including Clinical Operations, Commercial, Regulatory, and Medical Affairs.
- Knowledge of clinical research and messaging, including study design, evaluation, medical writing, expert panel conduct, symposium and workshop management, and KOL management.
- A network of customer contacts in the therapeutic area.
- Capability in office work and project management.
About the company
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Company Size
10,001+
Company Stage
IPO
Headquarters
Thousand Oaks, California
Founded
1980
Get referred to Amgen
See people who can refer or advise you
Simplify's Take
What believers are saying
- Growth is broad-based: 22 products grew at least 10%, lifting June 2026 quarter revenue 10% to $10.1 billion.
- Stock grants gained value: Amgen shares rose 27% from January to October 9, 2026, versus 10% for rival Eli Lilly.
- Many U.S. roles are remote: 145 of Amgen's 615 U.S. job openings in October 2026 were fully remote.
What critics are saying
- Its 2025 best seller is shrinking: cheaper copies cut bone drug Prolia's sales 32% in the June 2026 quarter.
- MariTide, Amgen's obesity bet, faces a giant: Lilly's Mounjaro and Zepbound outsold all of Amgen in the June 2026 quarter.
- Most tech openings are in India: 156 of Amgen's 210 information systems jobs in October 2026 were in Hyderabad.
What makes Amgen unique
- It copies rivals' blockbusters too: Pavblu, its version of Regeneron's eye drug Eylea, sold $700 million in 2025.
- Amgen hunts drug targets in a nation's DNA: its Icelandic unit deCODE has genetic data on two-thirds of Iceland's adults.
- Amgen opened a U.S. cancer-drug class: Blincyto, approved in 2014, was the first to tether immune cells to cancer.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Professional Development Budget
- Conference Attendance Budget